These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 17159460

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia.
    Akhondzadeh S, Gerami M, Noroozian M, Karamghadiri N, Ghoreishi A, Abbasi SH, Rezazadeh SA.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec 12; 32(8):1810-5. PubMed ID: 18727948
    [Abstract] [Full Text] [Related]

  • 44. Sustained improvement of clinical outcome with risperidone long-acting injectable in psychotic patients previously treated with olanzapine.
    Gastpar M, Masiak M, Latif MA, Frazzingaro S, Medori R, Lombertie ER.
    J Psychopharmacol; 2005 Sep 12; 19(5 Suppl):32-8. PubMed ID: 16144784
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Improved symptom control, functioning and satisfaction in French patients treated with long-acting injectable risperidone.
    Llorca PM, Bouhours P, Moreau-Mallet V, French investigators group.
    Encephale; 2008 Apr 12; 34(2):170-8. PubMed ID: 18597725
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects.
    Hofer A, Kemmler G, Eder U, Edlinger M, Hummer M, Fleischhacker WW.
    J Clin Psychiatry; 2004 Jul 12; 65(7):932-9. PubMed ID: 15291682
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. The Risperidone Outcomes Study of Effectiveness (ROSE): a model for evaluating treatment strategies in typical psychiatric practice.
    Mahmoud R, Engelhart L, Ollendorf D, Oster G.
    J Clin Psychiatry; 1999 Jul 12; 60 Suppl 3():42-7; discussion 48. PubMed ID: 10073377
    [Abstract] [Full Text] [Related]

  • 56. Subjective response to clozapine and risperidone treatment in outpatients with schizophrenia.
    Kim JH, Kim SY, Ahn YM, Kim YS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar 12; 30(2):301-5. PubMed ID: 16309807
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. A 1-year double-blind study of 2 doses of long-acting risperidone in stable patients with schizophrenia or schizoaffective disorder.
    Simpson GM, Mahmoud RA, Lasser RA, Kujawa M, Bossie CA, Turkoz I, Rodriguez S, Gharabawi GM.
    J Clin Psychiatry; 2006 Aug 12; 67(8):1194-203. PubMed ID: 16965196
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission?
    Schennach-Wolff R, Jäger M, Obermeier M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Kühn KU, Lemke MR, Rüther E, Klingberg S, Gastpar M, Seemüller F, Möller HJ, Riedel M.
    World J Biol Psychiatry; 2010 Aug 12; 11(5):729-38. PubMed ID: 20380620
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.